Amazon.Com INC (AMZN) Valuation Rose While Bluestein R H & Company Has Cut Its Position

July 14, 2018 - By Tamara Reed

Amazon.com, Inc. (NASDAQ:AMZN) LogoInvestors sentiment decreased to 1.08 in Q1 2018. Its down 0.21, from 1.29 in 2017Q4. It turned negative, as 73 investors sold AMZN shares while 659 reduced holdings. 173 funds opened positions while 614 raised stakes. 266.38 million shares or 4.87% less from 280.02 million shares in 2017Q4 were reported. Bellecapital Limited stated it has 5.78% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Moreover, Private Wealth Advsrs has 1.96% invested in Amazon.com, Inc. (NASDAQ:AMZN). 1,531 are owned by Two Sigma Securities Ltd Company. Fragasso Gp Inc stated it has 0.07% in Amazon.com, Inc. (NASDAQ:AMZN). Shell Asset Mgmt Co stated it has 36,534 shares or 1.05% of all its holdings. Friess Associate Limited Liability Company has invested 3.4% in Amazon.com, Inc. (NASDAQ:AMZN). Kayne Anderson Rudnick Inv Lc invested in 53,788 shares or 0.58% of the stock. California-based Roof Eidam Maycock Adv has invested 0.12% in Amazon.com, Inc. (NASDAQ:AMZN). 761,473 were reported by National Bank & Trust Of Montreal Can. Da Davidson And Company owns 12,962 shares for 0.39% of their portfolio. Jacobson Schmitt Limited invested 4.05% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Moreover, Grandfield Dodd Lc has 0.06% invested in Amazon.com, Inc. (NASDAQ:AMZN) for 356 shares. Hermes Mngmt reported 99,164 shares. Taurus Asset Management Ltd Com owns 6,884 shares or 1.5% of their US portfolio. Raymond James invested 0.85% in Amazon.com, Inc. (NASDAQ:AMZN).

Since February 15, 2018, it had 0 buys, and 21 insider sales for $63.19 million activity. $2.99 million worth of Amazon.com, Inc. (NASDAQ:AMZN) shares were sold by WILKE JEFFREY A. 435 Amazon.com, Inc. (NASDAQ:AMZN) shares with value of $686,439 were sold by Reynolds Shelley. Jassy Andrew R sold $2.72M worth of stock. STONESIFER PATRICIA Q also sold $2.17M worth of Amazon.com, Inc. (NASDAQ:AMZN) on Wednesday, May 2. Olsavsky Brian T sold 2,333 shares worth $3.42M. On Thursday, February 15 ALBERG TOM A sold $3.35 million worth of Amazon.com, Inc. (NASDAQ:AMZN) or 2,285 shares.

Bluestein R H & Company decreased its stake in Amazon.Com Inc (AMZN) by 4% based on its latest 2018Q1 regulatory filing with the SEC. Bluestein R H & Company sold 2,567 shares as the company’s stock rose 5.80% while stock markets declined. The hedge fund held 61,617 shares of the consumer services company at the end of 2018Q1, valued at $89.18 million, down from 64,184 at the end of the previous reported quarter. Bluestein R H & Company who had been investing in Amazon.Com Inc for a number of months, seems to be less bullish one the $879.73B market cap company. The stock increased 0.91% or $16.41 during the last trading session, reaching $1813.03. About 4.20M shares traded or 2.76% up from the average. Amazon.com, Inc. (NASDAQ:AMZN) has risen 62.09% since July 14, 2017 and is uptrending. It has outperformed by 49.52% the S&P500.

Bluestein R H & Company, which manages about $2.94 billion and $1.82 billion US Long portfolio, upped its stake in Abiomed Inc (NASDAQ:ABMD) by 13,995 shares to 18,395 shares, valued at $5.35M in 2018Q1, according to the filing. It also increased its holding in Johnson & Johnson (NYSE:JNJ) by 131,091 shares in the quarter, for a total of 150,926 shares, and has risen its stake in Edwards Lifesciences (NYSE:EW).

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on July, 26. They expect $2.50 EPS, up 525.00 % or $2.10 from last year’s $0.4 per share. AMZN’s profit will be $1.21 billion for 181.30 P/E if the $2.50 EPS becomes a reality. After $3.27 actual EPS reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -23.55 % negative EPS growth.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Seekingalpha.com which released: “Amazon: Taking Over The World” on July 06, 2018, also Benzinga.com with their article: “The Evolution Of Amazon’s Prime Day” published on July 13, 2018, Seekingalpha.com published: “CNBC: Amazon, Xealth plan healthcare delivery pilot” on July 12, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Seekingalpha.com and their article: “If There’s One (Non-Consensus) Bull Case On Amazon, This Is It” published on July 12, 2018 as well as Seekingalpha.com‘s news article titled: “Amazon Will Become A Network Vendor” with publication date: July 14, 2018.

Amazon.com, Inc. (NASDAQ:AMZN) Ratings Coverage

Among 38 analysts covering Amazon (NASDAQ:AMZN), 38 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amazon has $2100 highest and $1360.0 lowest target. $1784.14’s average target is -1.59% below currents $1813.03 stock price. Amazon had 62 analyst reports since January 16, 2018 according to SRatingsIntel. The firm has “Buy” rating by M Partners given on Tuesday, May 29. The firm has “Buy” rating given on Friday, February 2 by Aegis Capital. The firm has “Buy” rating by DA Davidson given on Monday, February 12. On Wednesday, April 11 the stock rating was reinitiated by Monness with “Buy”. The company was maintained on Tuesday, February 27 by Cowen & Co. Loop Capital Markets maintained the stock with “Buy” rating in Wednesday, February 28 report. As per Thursday, June 21, the company rating was maintained by UBS. The firm has “Overweight” rating given on Friday, April 27 by Barclays Capital. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Buy” rating given on Tuesday, January 30 by Guggenheim. RBC Capital Markets maintained the stock with “Buy” rating in Friday, February 2 report.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.